Insights from 2024 SGO Annual Meeting
B

SGO 2024 Insights: "innovaTV 301/ENGOT-cx12/GOG-3057 Study - Efficacy & Safety of Tisotumab Vedotin vs. Investigator's Choice of Chemo in 2L/3L Recurrent/Metastatic Cervical Cancer"

By Insights from 2024 SGO Annual Meeting FEATURING Brian Slomovitz
By Insights from 2024 SGO Annual Meeting FEATURING Brian Slomovitz
95 views
April 12, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

19:51
AstraZeneca Oncology

Management Strategies for Fatigue and Asthenia in First-line Mainten…

Feat. D. Czel, C. Arn

Featured Video

20:09
AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn

Related Content

AUTOPLAY
27:04
Fengting Yan

Cancer Screening Molecular Tools

06:07
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Feat. M. Raza Mirza
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
04:02
Total Health

2024 Updates in Cervical Cancer

Feat. T. Tillmanns
15:14
Brian Slomovitz

Update in Vulvar and Vaginal Cancer

07:56
Fengting Yan

Year in Review: Cervical Cancer

06:46
Total Health

Recent Highlights in Cervical Cancer

Feat. B. Slomovitz
13:41
UCLA Health

2024 Updates in Locally Advanced Cervical Cancer

Feat. D. Chase
12:45
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The GCIG INTERLACE Randomised Phase 3 Tria…

Feat. M. McCormack
44:59
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Updates on Cervical and Endometrial Cancers

Feat. K. Pennington
05:31
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "Impact of Maintenance Bevacizumab Following…

Feat. M. Kuznicki
04:58
Oncology Data Advisor

Tisotumab Vedotin for Metastatic Cervical Cancer: Updates From ESMO …

Feat. B. Slomovitz
10:27
Robert McBane

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…

11:37
UCLA Health

Recurrent Cervical Cancer Updates

Feat. R. Salani
12:21
Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "PARP Inhibitor Resistance Mechanisms in Gy…

Feat. V. Heinzelmann-Schwarz
11:02
SGO 2023 Conference Coverage on VuMedi

Chemoradiation for Stage IB3 Cervical Cancer

Feat. J. Mayadev
11:10
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "KEYNOTE-A18 Study - Pembro + CRT for High-…

Feat. D. Lorusso
07:05
Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "Understanding and Targeting BRCA & HRD…

Feat. V. Heinzelmann-Schwarz
08:24
Hope Cottrill

Tisotumab Vedotin in Advanced or Recurrent Cervical Cancer

23:38
Insights from 2023 IGCS Annual Meeting

IGCS 2023 Insights: "Is Immunotherapy Beating Stage 4B, Persist…

Feat. N. Colombo